REGULATORY INTELLIGENCEWarning Letter2024-07-03
Contract Pharmacal's Acetaminophen Recall Signals Persistent Quality Control Challenges
Contract Pharmacal Corporation has initiated a Class II voluntary recall of 14,616 bottles of Extra Strength Acetaminophen 500 MG Tablets due to discoloration. This event, prompted by brownish tablets, highlights ongoing quality control vulnerabilities for the Hauppauge, NY-based manufacturer, impacting supply chain stability for distributors like Major Pharmaceuticals and demanding immediate procurement re-evaluation.
Contract Pharmacal CorporationAcetaminophenContract Pharmacal Corporation — Manufacturing SiteHSN 30049099
PS
Priya Subramaniam
Intelligence Analyst
Trending signal